Ligtenberg, G.

patient group rejection withdrawal transplantation csa withdrawal group pred withdrawal group study mycophenolate mofetil pred withdrawal therapy graft mycophenolate effect randomization control group kidney mofetil incidence creatinine follow-up biopsy-proven infection serum creatinine 24 mo cyclosporine control table transplant biopsy calcineurin inhibitors prednisone function randomized nephrol difference trial csa withdrawal drug therapy month analysis medication result american society lipid metabolism kidney transplantation 18 mo treatment creatinine clearance serum discontinuation failure comparison cholesterol survival graft failure patient death number graft survival lipid clearance mmol /l ratio /pred american change antit cell therapy van gelder t death rejection episodes inhibitor calcineurin nephrology j nephrology hoitsma aj ratio pressure van es csa nephrotoxicity european conversion